

Hot shot: the wider promise of weight-loss jabs
Oct 30, 2024
Natasha Loda, Health editor for The Economist, dives into the transformative potential of GLP-1 drugs initially designed for diabetes, now being tested for broader health issues. Simon Rabinovich discusses the surprising disconnect between a booming US economy and the negative sentiment affecting voters as elections loom. Alice Su shares harrowing tales of Chinese migrants risking their lives through dangerous journeys to reach America, revealing the socio-political factors at play. Together, they explore pressing global health and migration issues intertwined with economic challenges.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Intro
00:00 • 2min
The Promise of GLP-1 Receptor Agonists
01:34 • 4min
The Promise of GLP Drugs in Weight Loss and Health
05:12 • 4min
Biden's Economic Landscape: Growth vs. Sentiment
09:17 • 7min
Journey of Hope: Chinese Migrants to the U.S.
16:32 • 6min
Navigating the Complexities of Asylum Seekers' Journeys
22:07 • 2min